CureVac N.V. (CVAC)
NASDAQ: CVAC · Real-Time Price · USD
3.300
+0.020 (0.61%)
At close: Feb 21, 2025, 4:00 PM
3.320
+0.020 (0.61%)
After-hours: Feb 21, 2025, 6:05 PM EST
CureVac Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for CureVac stock have an average target of 10, with a low estimate of 4.00 and a high estimate of 16. The average target predicts an increase of 203.03% from the current stock price of 3.30.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for CureVac stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Reiterates $16 | Buy | Reiterates | $16 | +384.85% | Feb 14, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $16 | Buy | Reiterates | $16 | +384.85% | Sep 16, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $18 → $16 | Buy | Maintains | $18 → $16 | +384.85% | Aug 16, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $18 | Buy | Reiterates | $18 | +445.45% | Jul 3, 2024 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $12 → $4 | Buy → Hold | Downgrades | $12 → $4 | +21.21% | Apr 25, 2024 |
Financial Forecast
Revenue This Year
452.95M
from 53.76M
Increased by 742.57%
Revenue Next Year
65.73M
from 452.95M
Decreased by -85.49%
EPS This Year
0.76
from -1.18
EPS Next Year
-0.52
from 0.76
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 570.2M | 162.8M | 158.6M | |||
| Avg | 453.0M | 65.7M | 109.3M | |||
| Low | n/a | n/a | 77.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 960.6% | -64.1% | 141.2% | |||
| Avg | 742.6% | -85.5% | 66.3% | |||
| Low | - | - | 17.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.21 | -0.12 | -0.13 |
| Avg | 0.76 | -0.52 | -0.29 |
| Low | 0.50 | -0.74 | -0.44 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.